Cancer BiologybioRxiv
The differential metabolic signature of breast cancer cellular response to olaparib treatment
D. Berardi, Y. Hunter, L. van den Driest…·Z. Rattray
This study identifies cell-line and dose-dependent metabolic changes in breast cancer cells treated with olaparib, highlighting glutamine and lipid metabolism reprogramming and DNA damage foci accumulation.
DOI 10.3390/cancers14153661